Your browser doesn't support javascript.
loading
Inhibition of PDE4 by FCPR16 induces AMPK-dependent autophagy and confers neuroprotection in SH-SY5Y cells and neurons exposed to MPP+-induced oxidative insult.
Zhong, Jiahong; Xie, Jinfeng; Xiao, Jiao; Li, Dan; Xu, Bingtian; Wang, Xinyi; Wen, Huizhen; Zhou, Zhongzhen; Cheng, Yufang; Xu, Jiangping; Wang, Haitao.
Afiliação
  • Zhong J; Department of Neuropharmacology and Drug Discovery, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, 510515, China.
  • Xie J; Department of Neuropharmacology and Drug Discovery, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, 510515, China.
  • Xiao J; Department of Neuropharmacology and Drug Discovery, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, 510515, China.
  • Li D; Department of Neuropharmacology and Drug Discovery, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, 510515, China.
  • Xu B; Department of Neuropharmacology and Drug Discovery, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, 510515, China; Central Laboratory, Southern Medical University, Guangzhou, 510515, China.
  • Wang X; Department of Neuropharmacology and Drug Discovery, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, 510515, China.
  • Wen H; Central Laboratory, Southern Medical University, Guangzhou, 510515, China.
  • Zhou Z; Department of Neuropharmacology and Drug Discovery, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, 510515, China.
  • Cheng Y; Central Laboratory, Southern Medical University, Guangzhou, 510515, China.
  • Xu J; Department of Neuropharmacology and Drug Discovery, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, 510515, China; Central Laboratory, Southern Medical University, Guangzhou, 510515, China; Center for Brian Science and Brain-Inspired Intelligence, Guangdong-Hong Kong-Macao
  • Wang H; Department of Neuropharmacology and Drug Discovery, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, 510515, China; Center for Brian Science and Brain-Inspired Intelligence, Guangdong-Hong Kong-Macao Greater Bay Area, China; Key Laboratory of Mental Health of the Ministry o
Free Radic Biol Med ; 135: 87-101, 2019 05 01.
Article em En | MEDLINE | ID: mdl-30818055

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Benzamidas / Nucleotídeo Cíclico Fosfodiesterase do Tipo 4 / Inibidores da Fosfodiesterase 4 Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Benzamidas / Nucleotídeo Cíclico Fosfodiesterase do Tipo 4 / Inibidores da Fosfodiesterase 4 Idioma: En Ano de publicação: 2019 Tipo de documento: Article